Funder: Eli Lilly and Company
Due Dates (Anticipated): October 2026 (Full application deadline, projected)
Funding Amounts: Award size and duration vary by project; funding supports full study costs as proposed by the investigator.
Summary: Supports independent, externally sponsored clinical research aligned with Lilly’s scientific priorities through a competitive RFP process.
Key Information: This is a forecasted opportunity; actual RFP topics and budgets may change.